Here are relevant reports on : vaccine-immunization-devices-market
-
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) - Global Forecast to 2029
The global microcarriers market, valued at US$2.03B in 2023, is forecasted to grow at a 8.0% CAGR, reaching US$2.08B by 2024 and US$3.05B by 2029. Market growth is attributed to rising investments in cell & gene therapy research, growing preference for single-use technologies, and increasing R&D spending for biopharmaceutical production.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022
The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Laboratory Freezers Market by Modality (Cryopreservation; Freezer: ULTF, Plasma, Enzyme; Refrigerator: Blood Bank, Pharmacy, Chromatography), Application (Genetic, Vaccine, Biological Sample), End User (Hospital, Pharma, Cell Bank)-Global Forecast to 2031
The global laboratory freezers market is projected to reach USD 5.11 billion by 2031, growing at a CAGR of 3.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Supplies Market by Service [Manufacturing, Packaging (Primary, Secondary), Logistics], Phases, Type (Small Molecules, Biologics, Vaccine), Therapeutic Areas (Oncology, Neurology, Ophthalmology, Dermatology), Region - Global Forecast to 2031
The global clinical trial supplies market is projected to reach USD 8.95 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Medical Devices Market Size by Type (In Vitro Diagnostic Devices, Cardiovascular, Imaging, Ophthalmology, Endoscopy, Orthopedic, Diabetes Care, Wound Care Devices, Kidney/Dialysis Devices, Respiratory Care), Region - Global Forecast to 2031
The global medical devices market is projected to reach USD 817.78 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 8150
- TOC Available:
-
Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
The global medical device reprocessing market growth is primed to transition from USD 2.0 billion in 2022 to USD 3.9 billion by 2027, showcasing a strong CAGR of 13.7%. Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031
The global peripheral vascular devices market, valued at USD 9.55 billion in 2025, stood at USD10.02 billion in 2026 and is projected to advance at a resilient CAGR of 5.7% from 2026 to 2031, culminating in a forecasted valuation of USD13.22 billion by the end of the period. The market for peripheral vascular devices is anticipated to grow due to several factors, including the rising incidence of peripheral artery disease and diabetes, an increasingly aging global population, and a preference for minimally invasive endovascular procedures that reduce hospital stays and recovery times.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Gastrointestinal Products Market | Gastroenterology Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Global Forecast to 2029
The global gastrointestinal products market, valued at US$13.8 million in 2023, stood at US$14.7 million in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$19.7 million by the end of the period. Market growth can be attributed to the growing prevalence of gastrointestinal diseases such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and colorectal cancer, which drives the demand for diagnostic and therapeutic products.
- Published: August 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
